COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Therapeutic Protein Drug Products - 1st Edition - ISBN: 9781907568183, 9781908818102

Therapeutic Protein Drug Products

1st Edition

Practical Approaches to formulation in the Laboratory, Manufacturing, and the Clinic

Editor: Brian Meyer
Hardcover ISBN: 9781907568183
eBook ISBN: 9781908818102
Imprint: Woodhead Publishing
Published Date: 2nd January 2012
Page Count: 200
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

List of figures and tables


About the authors

Chapter 1: Commercial therapeutic protein drug products


1.1 Introduction

1.2 Lyophilized formulations

1.3 Liquid formulations

1.4 Protein formulations for radiologic and diagnostic use

1.5 Summary

Chapter 2: A formulation method to improve the physical stability of macromolecular-based drug products


2.1 Introduction

2.2 Common techniques used for the construction of EPDs

2.3 The peptide drug pramlintide

2.4 Monoclonal antibodies at low and high concentration

2.5 Static vs. dynamic EPDs: a case study using a humanized immunoglobulin (IgG1)

2.6 Conclusion and future studies

Chapter 3: Properties of protein formulations


3.1 Introduction

3.2 Opalescence

3.3 Phase separation

3.4 Color

3.5 Subvisible particles

Chapter 4: Material and process compatibility testing


4.1 Introduction

4.2 Material compatibility

4.3 Process compatibility testing

4.4 Antimicrobial preservative compatibility testing

Chapter 5: Compounding and filling: drug substance to drug product


5.1 Introduction

5.2 Aseptic processing

5.3 Bulk drug substance

5.4 Compounding of drug product

5.5 Filling the drug product

Chapter 6: Administration in the clinic


6.1 Introduction and background

6.2 Diluents

6.3 Components

6.4 Construction materials

6.5 Clinical dosing strategy: fixed volume versus fixed concentration

6.6 Representative admixture concentration levels

6.7 Exposure temperature and time

6.8 Option of using syringes

6.9 Analytical tests and acceptance criteria

6.10 Sample preparation considerations

6.11 Role of probe studies

6.12 Bag overfill volume

6.13 Pharmacy instructions

6.14 Conclusions

Chapter 7: Regulatory guidelines for the development of a biotechnology drug product


7.1 Introduction

7.2 ICH overview

7.3 Common Technical Document (CTD)

7.4 Drug product dossier

7.5 Regulatory considerations through the biotechnology product lifecycle

7.6 Conclusions


Recommended reading



Therapeutic protein drug products provides a comprehensive overview of therapeutic protein drug products, with an emphasis on formulation beginning in the laboratory, followed by manufacturing and administration in the clinic. A list of many commercial therapeutic drug products are described and include the product name, dosages, active concentration, buffer, excipients, Ph, container type and route of administration. The laboratory formulation sections focus on the most common buffers, excipients, and Ph ranges that are commonly tested in addition to systematic approaches. A brief section on biophysical and analytical analysis is also provided. Properties of therapeutic protein formulations are described and include opalescence, phase separation, color, and subvisible particles. An emphasis is placed on material and process testing to ensure success during manufacturing. The drug product manufacturing process, which includes the process of compounding to filling, is also covered. Methods of delivery in the clinic are addressed, as well as delivery strategies. Finally, a perspective on the regulatory requirements for therapeutic protein formulations is discussed.

Key Features

  • Provides a list and description of commercially available therapeutic drug products and their formulations
  • A comprehensive and practical overview of protein formulation in the laboratory, manufacturing, and the clinic
  • Discusses recent topics including high protein concentration, phase separation, opalescence, and subvisible particles


The pharmaceutical and biotechnology industries


No. of pages:
© Woodhead Publishing 2012
2nd January 2012
Woodhead Publishing
Hardcover ISBN:
eBook ISBN:

Ratings and Reviews

About the Editor

Brian Meyer

Dr Brian K. Meyer is a Research Fellow in Bioprocess Research and Development, Merck Research Laboratories (MRL). Dr Meyer's current position is leading a group in Vaccine Drug Product Development. Previously, Dr Meyer's team was responsible for formulating therapeutic proteins in pre-clinical development. Prior to joining MRL, Dr Meyer was a Process Scientist in Vaccine Technology and Engineering, Merck Manufacturing Division. He has a Ph.D. in Biochemistry, Microbiology, and Molecular Biology from The Pennsylvania State University and a B.S.E. in Biomedical Engineering from Tulane University.

Affiliations and Expertise

Merck Research Laboratories (MRL), USA